Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients

Clinical trial NCT03710655 · UNKNOWN

Trial details

NCT number: NCT03710655
Sponsor: Apimeds, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2019-04-01
Primary completion: 2019-08-01
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.